Company Filing History:
Years Active: 2011-2013
Title: Mohammed Amin Khan: Innovator in GLP-1 Formulations
Introduction
Mohammed Amin Khan is a notable inventor based in Palo Alto, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on glucose-like peptide-1 (GLP-1) compounds. With a total of 2 patents, his work is paving the way for advancements in oral absorption methods.
Latest Patents
Khan's latest patents include a formulation comprising GLP-1 and a method for administering GLP-1 molecules. The first patent relates to formulations that demonstrate the feasibility of oral absorption of GLP-1 compounds and specified delivery agents. It also outlines methods for stimulating the GLP-1 receptor in subjects who require such stimulation through the administration of the formulation. The second patent similarly focuses on the oral absorption of GLP-1 compounds and the methods for their effective delivery.
Career Highlights
Khan is currently associated with Emisphere Technologies, Inc., where he continues to innovate in the field of drug delivery systems. His work is crucial in developing new therapeutic options for patients in need of GLP-1 receptor stimulation.
Collaborations
Some of his notable coworkers include Bryan Edward Jones and John McNeil McGill, who contribute to the collaborative efforts in research and development at Emisphere Technologies, Inc.
Conclusion
Mohammed Amin Khan's contributions to GLP-1 formulations represent a significant advancement in pharmaceutical science. His innovative work continues to impact the field positively, offering new possibilities for oral drug delivery systems.